Product Information
TACROLIMUS 0.1% OINTMENT is a generic product labeled by Encube Ethicals, Inc., priced at $0.9560 per GM under NDC 21922001105. Its NADAC has been published 132 times since Feb 14, 2024.
FDA first approved this application on Oct 10, 2023. Its Orange Book therapeutic-equivalence code is BX.
Strength
1 mg/g
Manufacturer
Encube Ethicals, Inc.NDC
21922001105
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA212387FDA Approved
10/10/2023
TE Code
BX
On Market Since
10/13/2023
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.1% OINTMENT has been published 132 times since Feb 14, 2024, and over the history we have for it it has declined 23.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9560 per GM |
|---|---|
| All-time high | $1.3572 (Apr 10, 2024) |
| All-time low | $0.7143 (Nov 20, 2024) |
| 52-week high | $1.0368 |
| 52-week low | $0.9245 |
| Median price | $0.9851 |
| Average price | $1.0123 |
| Largest weekly change | +41.4% (Aug 21, 2024) |
| Weeks tracked | 132 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.1% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.1% OINTMENT, manufactured by Encube Ethicals, Inc., is $0.9560 per GM (NDC 21922001105), effective Aug 19, 2026.
How has the price of TACROLIMUS 0.1% OINTMENT changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.1% OINTMENT has declined 23.2%. It has been tracked across 132 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.1% OINTMENT?
Since Feb 14, 2024, the NADAC for TACROLIMUS 0.1% OINTMENT has ranged from a low of $0.7143 (Nov 20, 2024) to a high of $1.3572 (Apr 10, 2024), with a median of $0.9851 per GM.
Are there cheaper alternatives to TACROLIMUS 0.1% OINTMENT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TACROLIMUS 0.1% OINTMENT, is $0.9192 per GM — about 4% below TACROLIMUS 0.1% OINTMENT.
Who manufactures TACROLIMUS 0.1% OINTMENT?
TACROLIMUS 0.1% OINTMENT (NDC 21922001105) is labeled by Encube Ethicals, Inc., and CMS classifies it as a generic product.